Addiction Treatment Medicine Is Vastly Underprescribed, Especially by Race, Study Findsnews2023-05-10T21:49:51+00:00May 10th, 2023|The New York Times|
A Statin Alternative Joins Drugs That Can Reduce Heart Attack Risknews2023-03-04T16:58:34+00:00March 4th, 2023|The New York Times|
FDA Approves, Leqembi, New Treatment for Early Alzheimer’snews2023-01-06T22:58:48+00:00January 6th, 2023|The New York Times|
Alzheimer’s Drug May Benefit Some Patients, New Data Showsnews2022-11-30T00:50:06+00:00November 30th, 2022|The New York Times|
The Disease Took Zara, Then Sara. Could Ayla Be Saved?news2022-11-09T22:00:17+00:00November 9th, 2022|The New York Times|
Un fármaco para la alopecia recibe aprobación de la FDAnews2022-06-14T19:39:55+00:00June 14th, 2022|The New York Times|
F.D.A. Approves Alopecia Drug That Restores Hair Growth in Many Patientsnews2022-06-13T21:35:59+00:00June 13th, 2022|The New York Times|
Enhertu Breast Cancer Drug Results in ‘Unheard-of’ Survival Ratesnews2022-06-07T21:22:33+00:00June 7th, 2022|The New York Times|
Un ensayo sobre cáncer da un resultado inesperado: remisión en todos los pacientesnews2022-06-07T09:00:17+00:00June 7th, 2022|The New York Times|
Small Study on Rectal Cancer Results in Remission in Every Patientnews2022-06-05T18:09:29+00:00June 5th, 2022|The New York Times|
